We also aimed to measure and compare the levels of B-lymphocyte subsets (based on CD27 and CD38 expression), T-lymphocyte subsets (CD4 helper and CD8 cytotoxic), and monocyte subsets (based on CD14 and CD16 markers) in patients with T2DM and healthy controls. Here, CD14 is linked to type 2 diabetes mellitus.